ArticleJournal of biomedical science2019

Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets.

Chia-Hung Chien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.